KPIs & Operating Metrics(New)

Breakdown Of Assets Employee Statistics Gastroenterology Revenue By Category Gastroenterology Revenue By Category Annual Hereditary Angioedema By Category Annual Neuroscience Revenue By Category Neuroscience Revenue By Category Annual Non Current Assets By Geography Annual Non Gaap Profitability Non Gaap Profitability %Non Gaap Profitability Annual Non Gaap Profitability Annual %Oncology Revenue By Category Oncology Revenue By Category Annual Opex As A % Of Total Revenue %OPEX Segregation Other Revenue By Category Other Revenue By Category Annual Pdt Immunology Revenue By Category Pdt Immunology Revenue By Category Annual Property, Plant And Equipment, Net Breakdown Rare Genetics And Other Revenue By Category Rare Hematology Revenue By Category Rare Hematology Revenue By Category Annual Rare Metabolic Revenue By Category Annual Remaining Performance Obligations Revenue By Category Rare Diseases Revenue By Region Revenue By Region %Revenue By Region Annual Revenue By Region Annual %Revenue By Therapeutic Area Revenue By Therapeutic Area %Revenue By Therapeutic Area Annual Revenue By Therapeutic Area Annual %Revenue By Type Of Good Or Service Revenue By Type Of Good Or Service %Revenue By Type Of Good Or Service Annual Revenue By Type Of Good Or Service Annual %

Daily Values

Growth Metrics

Income Statement

Others

Ratios

Takeda Pharmaceutical (TAK) Gastroenterology Revenue By Category (2016 - 2024)